This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lee, H.-S. Articles by Kim, C. Y. Search for Related Content PubMed PubMed Citation Articles by Lee, H.-S. Articles by Kim, C. Y.

Therapeutic Efficacy of Transcatheter Arterial Chemoembolization as Compared With Hepatic Resection in Hepatocellular Carcinoma Patients With Compensated Liver Function in a Hepatitis B Virus–Endemic Area: A Prospective Cohort Study

From the Departments of Internal Medicine, Surgery, and Radiology, and Liver Research Institute, Seoul National University Hospital, and Department of Applied Statistics, Korea National Open University, Seoul, Korea.

Address reprint requests to Hyo-Suk Lee, MD, Department of Internal Medicine, Seoul National University Hospital, 28 Yungun-dong, Chongno-gu, Seoul 110-744, Korea; email: hsleemd{at}snu.ac.kr

PURPOSE: Identifying a special subgroup of hepatocellular carcinoma (HCC) patients who may benefit from transcatheter arterial chemoembolization (TACE) when compared with the standard treatment of hepatic resection (HR) warrants research in Asian countries.

PATIENTS AND METHODS: From January 1993 to December 1994, 182 patients with operable HCC (Child-Pugh class A and International Union Against Cancer [UICC] stage T1-3N0M0) were enrolled. After initial TACE and lipiodol computed tomography, 91 received HR and 91, who refused the operation, received repeated sessions of TACE. After stratification according to the tumor stage (UICC and Cancer of the Liver Italian Program [CLIP]) and lipiodol retention pattern, the survival rates of the two treatment groups were compared. The median follow-up period was 83 months.

RESULTS: As of December 31, 2000, 48 patients who underwent HR and 68 patients who underwent TACE had died. In a subgroup analysis according to tumor stage, the HR group survival rate was significantly higher than the TACE group in both UICC T1-2N0M0 (P = .0058) and CLIP 0 (P = .0027) subgroups. However, there was no significant difference in either UICC T3N0M0 (P = .7512) or CLIP 1-2 (P = .5366) subgroups. Even in patients with UICC T1-2N0M0 HCC, when lipiodol was compactly retained, the survival rate of the HR group was comparable to that of the TACE group (P = .0596).

CONCLUSION: TACE proved to be as effective as HR in the subpopulations with UICC T3N0M0 or CLIP 1-2 HCC and adequate liver function, and even with UICC T1-2N0M0 HCC when lipiodol was compactly retained in the tumor. In such cases, the choice of treatment modality between TACE and HR may be left to the patient’s preference.

This article has been cited by other articles:

				D. D. Seo, H. C. Lee, M. K. Jang, H. J. Min, K. M. Kim, Y. S. Lim, Y.-H. Chung, Y. S. Lee, D. J. Suh, G.-Y. Ko, et al. Preoperative Portal Vein Embolization and Surgical Resection in Patients with Hepatocellular Carcinoma and Small Future Liver Remnant Volume: Comparison with Transarterial Chemoembolization Ann. Surg. Oncol., December 1, 2007; 14(12): 3501 - 3509. [Abstract] [Full Text] [PDF]

				J. Yamamoto, T. Kosuge, A. Saiura, Y. Sakamoto, K. Shimada, T. Sano, T. Takayama, Y. Sugawara, T. Yamaguchi, N. Kokudo, et al. Effectiveness of Hepatic Resection for Early-stage Hepatocellular Carcinoma in Cirrhotic Patients: Subgroup Analysis according to Milan Criteria Jpn. J. Clin. Oncol., April 1, 2007; 37(4): 287 - 295. [Abstract] [Full Text] [PDF]

				K. S. Chok, K. K. Ng, R. T. P. Poon, C. M. Lam, J. Yuen, W. K. Tso, and S. T. Fan Comparable Survival in Patients With Unresectable Hepatocellular Carcinoma Treated by Radiofrequency Ablation or Transarterial Chemoembolization Arch Surg, December 1, 2006; 141(12): 1231 - 1236. [Abstract] [Full Text] [PDF]

				Y. I. Kim, J. W. Chung, J. H. Park, J. K. Han, J. W. Hong, and H. Chung Intraarterial Gene Delivery in Rabbit Hepatic Tumors: Transfection with Nonviral Vector by Using Iodized Oil Emulsion Radiology, September 1, 2006; 240(3): 771 - 777. [Abstract] [Full Text] [PDF]

				H.-C. Kim, J. W. Chung, W. Lee, H. J. Jae, and J. H. Park Recognizing Extrahepatic Collateral Vessels That Supply Hepatocellular Carcinoma to Avoid Complications of Transcatheter Arterial Chemoembolization RadioGraphics, October 1, 2005; 25(suppl_1): S25 - S39. [Abstract] [Full Text] [PDF]